Showing results (201-210 of 308) with videos related to

Sort By:
Pageof 31
Journal of Clinical Epidemiology|April 27, 2026
Discriminating clinical prediction models: how outcome incidence and decision thresholds shape clinical utility and apt AUROC valuesFarid Foroutan, Jessica Weiss, Martin Mayer, et al.
Research Synthesis Methods|November 24, 2019
Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied exampleValentijn M T de Jong, Karel G M Moons, Richard D Riley, et al.
Statistics in Medicine|August 17, 2021
A tutorial on individualized treatment effect prediction from randomized trials with a binary endpointJeroen Hoogland, Joanna IntHout, Michail Belias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profilingMaurice P H M Jansen, John A Foekens, Iris L van Staveren, et al.
American Journal of Cancer Research|May 18, 2016
SIAH2 protein expression in breast cancer is inversely related with ER status and outcome to tamoxifen therapyKimberly D van der Willik, Mieke M Timmermans, Carolien Hm van Deurzen, et al.
Breast Cancer Research and Treatment|April 18, 2013
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifenDiana E Ramirez-Ardila, Jean C Helmijr, Maxime P Look, et al.
Oncotarget|December 15, 2015
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancerTommaso De Marchi, Anne M Timmermans, Marcel Smid, et al.
BMJ Open|August 31, 2025
Design aspects for prognostic factor studiesPeggy Sekula, Inga Steinbrenner, Ulla T Schultheiss, et al.
Plos Medicine|February 9, 2013
Prognosis Research Strategy (PROGRESS) 3: prognostic model researchEwout W Steyerberg, Karel G M Moons, Danielle A van der Windt, et al.
Pageof 31